Concepedia
Statistics
Publications
9
Citations
356
H-Index
Active since
2012
Affiliations
The University of Tokyo(Current)
Saitama Medical University
Teikyo University
National Center for Global Health and Medicine
University of California, San Francisco
Takahiro Koso is an author at The University of Tokyo specializing in oncology, molecular oncology, and medicine.
Publications per year
2012–2024
Genotype-Dependent Efficacy of a Dual PI3K/mTOR Inhibitor, NVP-BEZ235, and an mTOR Inhibitor, RAD001, in Endometrial Carcinomas
Keiko Shoji, Katsutoshi Oda, Tomoko Kashiyama et al. · PLoS ONE · 2012 · 82 citations · Full text
Medicine, Oncology, Pharmacology +17
Anti-tumor activity of olaparib, a poly (ADP-ribose) polymerase (PARP) inhibitor, in cultured endometrial carcinoma cells
Aki Miyasaka, Katsutoshi Oda, Yuji Ikeda et al. · BMC Cancer · 2014 · 63 citations · Full text
Medicine, Oncology, Pharmacology +15
Integrated Copy Number and Expression Analysis Identifies Profiles of Whole-Arm Chromosomal Alterations and Subgroups with Favorable Outcome in Ovarian Clear Cell Carcinomas
Yuriko Uehara, Katsutoshi Oda, Yuji Ikeda et al. · PLoS ONE · 2015 · 54 citations · Full text
Medicine, Genetics, Oncology +17
Antitumor Activity and Induction of TP53-Dependent Apoptosis toward Ovarian Clear Cell Adenocarcinoma by the Dual PI3K/mTOR Inhibitor DS-7423
Tomoko Kashiyama, Katsutoshi Oda, Yuji Ikeda et al. · PLoS ONE · 2014 · 51 citations · Full text
MDM2 is a potential therapeutic target and prognostic factor for ovarian clear cell carcinomas with wild type TP53
Chinami Makii, Katsutoshi Oda, Yuji Ikeda et al. · Oncotarget · 2016 · 43 citations · Full text
Medicine, Gynecology, Oncology +12
1–5 of 9